Abstract
Background: Nanoparticles (NPs) are a group of particles with at least one dimension ranging from 1 nm to 100 nm in diameter and a surrounding interfacial layer. The NP-protein interactions include covalent and non-covalent bonds. Several dehydrogenase enzymes (e.g., alcohol dehydrogenase, lactate dehydrogenase, alanine dehydrogenase, glutamate dehydrogenase, leucine dehydrogenase, phenylalanine dehydrogenase, and malate dehydrogenase) are used for immobilization by NPs. Also, magnetic NPs and quantum dots are promising model systems for the design of bioanalytical sensors and biological enzyme assemblies. In this overview, we aimed to improve the current knowledge of interactions between dehydrogenase enzymes and NPs and to introduce dehydrogenases with industrial and medical applications. Also, bioconjugation of NPs with dehydrogenase enzymes has broad applications in biocatalysis and nanomedicine in the field of drug discovery. However, studies on the characterization of NP-enzyme complexes show that the anatomy and activity of enzymes are dependent on the chemistry of NP ligands, NP size, and labeling methods. Moreover, the NPprotein conjugates show increased/decreased enzymatic activities, depending on the NP features.
Conclusion: In this study, we reviewed the findings related to NP-enzyme interactions for nanotechnology applications and conjugation techniques. We also highlighted several challenges associated with the NP-enzyme interactions, including the stability and reusability of enzymes in NP-enzyme formation.
Keywords: Dehydrogenase enzymes, Protein-ligand interaction, Immobilization, Magnetic nanoparticles, Quantum dots, Nanotechnology, Biosensors.
Mini-Reviews in Medicinal Chemistry
Title:Interaction of Dehydrogenase Enzymes with Nanoparticles in Industrial and Medical Applications, and the Associated Challenges: A Mini-review
Volume: 21 Issue: 11
Author(s): Samaneh J. Porzani, Adriana S. Lorenzi, Masoumeh Eghtedari and Bahareh Nowruzi*
Affiliation:
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran,Iran
Keywords: Dehydrogenase enzymes, Protein-ligand interaction, Immobilization, Magnetic nanoparticles, Quantum dots, Nanotechnology, Biosensors.
Abstract:
Background: Nanoparticles (NPs) are a group of particles with at least one dimension ranging from 1 nm to 100 nm in diameter and a surrounding interfacial layer. The NP-protein interactions include covalent and non-covalent bonds. Several dehydrogenase enzymes (e.g., alcohol dehydrogenase, lactate dehydrogenase, alanine dehydrogenase, glutamate dehydrogenase, leucine dehydrogenase, phenylalanine dehydrogenase, and malate dehydrogenase) are used for immobilization by NPs. Also, magnetic NPs and quantum dots are promising model systems for the design of bioanalytical sensors and biological enzyme assemblies. In this overview, we aimed to improve the current knowledge of interactions between dehydrogenase enzymes and NPs and to introduce dehydrogenases with industrial and medical applications. Also, bioconjugation of NPs with dehydrogenase enzymes has broad applications in biocatalysis and nanomedicine in the field of drug discovery. However, studies on the characterization of NP-enzyme complexes show that the anatomy and activity of enzymes are dependent on the chemistry of NP ligands, NP size, and labeling methods. Moreover, the NPprotein conjugates show increased/decreased enzymatic activities, depending on the NP features.
Conclusion: In this study, we reviewed the findings related to NP-enzyme interactions for nanotechnology applications and conjugation techniques. We also highlighted several challenges associated with the NP-enzyme interactions, including the stability and reusability of enzymes in NP-enzyme formation.
Export Options
About this article
Cite this article as:
Porzani J. Samaneh , Lorenzi S. Adriana, Eghtedari Masoumeh and Nowruzi Bahareh *, Interaction of Dehydrogenase Enzymes with Nanoparticles in Industrial and Medical Applications, and the Associated Challenges: A Mini-review, Mini-Reviews in Medicinal Chemistry 2021; 21 (11) . https://dx.doi.org/10.2174/1570193X17666201119152944
DOI https://dx.doi.org/10.2174/1570193X17666201119152944 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases
Current Drug Targets - CNS & Neurological Disorders Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design
Current Medicinal Chemistry Rapid and Solventless Analysis of Polychlorinated Biphenyls in Packaged Milk Using Gas Chromatography
Current Chromatography The Nearest-Neighbor Effect on Random-Coil NMR Chemical Shifts Demonstrated Using a Low-Complexity Amino-Acid Sequence
Protein & Peptide Letters The Panomics Approach in Neurodegenerative Disorders
Current Medicinal Chemistry Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Commentary((Research Highlights)(Amyotrophic Lateral Sclerosis: Targeting the Body’s Energy Engine))
CNS & Neurological Disorders - Drug Targets Acute Effects of Neutrophil-Derived Oxidative Stress on Pulmonary Microvasculature
Current Respiratory Medicine Reviews Editorial [Hot Topic: Drug Discovery for CNS Disorders: From Bench to Bedside (Guest Editor: Tiago Fleming Outeiro)]
CNS & Neurological Disorders - Drug Targets Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
Current Medicinal Chemistry Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Current Bioactive Compounds Implication of Rho GTPases in Neurodegenerative Diseases
Current Drug Targets Using Mass Spectrometry-Based Peptidomics to understand the Brain and Disorders such as Parkinson’s Disease and Schizophrenia
Current Topics in Medicinal Chemistry Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction
Current Topics in Medicinal Chemistry Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis
Current Neurovascular Research